Demand fluctuations caused by COVID-19
First written in FY2021. 9 of 12 entries say "Restated". Latest entry: FY2026-H1.
The whole theme swung hardest in 2020: 110 of 173 companies on the "Worse" side.
35 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「During the interim consolidated accounting period, there were no new business risks or material changes to the business risks described in the annual securities report for the previous fiscal year.」
The company stated that there had been no new occurrence or material change in the risk of demand fluctuations caused by COVID-19. - FY2025-H1RestatedAnnual report
「During the interim consolidated accounting period, there were no new business risks or material changes to the business risks described in the annual securities report for the previous fiscal year.」
The company stated that there had been no new occurrence or material change in the risk of demand fluctuations caused by COVID-19. - FY2025-Q1RestatedAnnual report
「During the cumulative first quarter of the fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company stated that there had been no new occurrence or material change in the risk of demand fluctuations caused by COVID-19. - FY2024SoftenedAnnual report
「The Japanese economy is recovering, particularly in service industries such as food service, as economic activity normalizes following the reclassification of COVID-19 to Category 5.」
COVID-19 was not presented as a separate major risk and was addressed in the context of its reclassification to Category 5 and the normalization of economic activity. - FY2023-Q3RestatedAnnual report
「During the nine months ended September, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the prior fiscal year.」
The company stated that there had been no new occurrence or material change in the risk of demand fluctuations caused by COVID-19. - FY2023-Q2RestatedAnnual report
「During the six months ended June, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the prior fiscal year.」
The company stated that there had been no new occurrence or material change in the risk of demand fluctuations caused by COVID-19. - FY2023-Q1RestatedAnnual report
「During the cumulative first-quarter period, both the impact of the spread of the Omicron variant and the impact of the situation in Ukraine were minor, and revenue remained strong.」
The impact of the spread of the Omicron variant continued to be described as minor. - FY2022RestatedAnnual report
「During the fiscal year, the impact of COVID-19 was minor, and revenue was on an upward trend in all of our businesses: optical measurement and new business areas, semiconductors and healthcare.」
The company continues to view the impact of COVID-19 as minor. - FY2022-Q3RestatedAnnual report
「We have determined that the impact of the spread of COVID-19 on the company is currently limited and will not materially affect the estimates for the fiscal year.」
The company continues to view the impact of COVID-19 as limited and maintains that there has been no material impact on accounting estimates. - FY2022-Q2RestatedAnnual report
「During the cumulative second-quarter period, the impact of COVID-19 was minor, and revenue remained generally steady.」
While the impact of COVID-19 continued to be described as minor, delivery delays occurred for some products. The company determined that the impact on accounting estimates was also limited. - FY2022-Q1MitigatedAnnual report
「During the cumulative first-quarter period, the impact of COVID-19 was minor, and revenue remained generally steady.」
The impact of the infection on the company's performance during the quarter was described as minor, indicating a more limited situation than the impact reported in the previous fiscal year. At the same time, concerns about an economic recovery due to variants and other factors continued to be noted. - FY2021First statedAnnual report
「Although some products were affected by COVID-19 during the fiscal year, both the semiconductor and healthcare businesses moved toward revenue growth, mainly from the second half.」
While revenue in the optical measurement and new business areas declined 8.8% year on year, healthcare recovered in the second half, indicating that the impact had materialized.